199 related articles for article (PubMed ID: 31599485)
1. A Chemical Biology Approach to Understanding Molecular Recognition of Lipid II by Nisin(1-12): Synthesis and NMR Ensemble Analysis of Nisin(1-12) and Analogues.
Dickman R; Danelius E; Mitchell SA; Hansen DF; Erdélyi M; Tabor AB
Chemistry; 2019 Nov; 25(64):14572-14582. PubMed ID: 31599485
[TBL] [Abstract][Full Text] [Related]
2. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
[TBL] [Abstract][Full Text] [Related]
3. Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B.
Dickman R; Mitchell SA; Figueiredo AM; Hansen DF; Tabor AB
J Org Chem; 2019 Sep; 84(18):11493-11512. PubMed ID: 31464129
[TBL] [Abstract][Full Text] [Related]
4. Environmental and dynamic effects explain how nisin captures membrane-bound lipid II.
Panina I; Krylov N; Nolde D; Efremov R; Chugunov A
Sci Rep; 2020 Jun; 10(1):8821. PubMed ID: 32483218
[TBL] [Abstract][Full Text] [Related]
5. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of the antimicrobial mechanism of mutacin 1140.
Smith L; Hasper H; Breukink E; Novak J; Cerkasov J; Hillman JD; Wilson-Stanford S; Orugunty RS
Biochemistry; 2008 Mar; 47(10):3308-14. PubMed ID: 18266322
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of bicyclic alkene-/alkane-bridged nisin mimics by ring-closing metathesis and their biochemical evaluation as lipid II binders: toward the design of potential novel antibiotics.
Ghalit N; Reichwein JF; Hilbers HW; Breukink E; Rijkers DT; Liskamp RM
Chembiochem; 2007 Sep; 8(13):1540-54. PubMed ID: 17674393
[TBL] [Abstract][Full Text] [Related]
8. New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.
't Hart P; Oppedijk SF; Breukink E; Martin NI
Biochemistry; 2016 Jan; 55(1):232-7. PubMed ID: 26653142
[TBL] [Abstract][Full Text] [Related]
9. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
[TBL] [Abstract][Full Text] [Related]
10. Docking and molecular dynamics simulations of the ternary complex nisin2:lipid II.
Mulholland S; Turpin ER; Bonev BB; Hirst JD
Sci Rep; 2016 Feb; 6():21185. PubMed ID: 26888784
[TBL] [Abstract][Full Text] [Related]
11. Lipid II as a target for antibiotics.
Breukink E; de Kruijff B
Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
[TBL] [Abstract][Full Text] [Related]
12. Targeting extracellular pyrophosphates underpins the high selectivity of nisin.
Bonev BB; Breukink E; Swiezewska E; De Kruijff B; Watts A
FASEB J; 2004 Dec; 18(15):1862-9. PubMed ID: 15576489
[TBL] [Abstract][Full Text] [Related]
13. Assembly and stability of nisin-lipid II pores.
Hasper HE; de Kruijff B; Breukink E
Biochemistry; 2004 Sep; 43(36):11567-75. PubMed ID: 15350143
[TBL] [Abstract][Full Text] [Related]
14. Towards the Native Binding Modes of Antibiotics that Target Lipid II.
Medeiros-Silva J; Jekhmane S; Breukink E; Weingarth M
Chembiochem; 2019 Jul; 20(14):1731-1738. PubMed ID: 30725496
[TBL] [Abstract][Full Text] [Related]
15. Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin.
van Heusden HE; de Kruijff B; Breukink E
Biochemistry; 2002 Oct; 41(40):12171-8. PubMed ID: 12356318
[TBL] [Abstract][Full Text] [Related]
16. In Bacterial Membranes Lipid II Changes the Stability of Pores Formed by the Antimicrobial Peptide Nisin.
Sheridan MS; Pandey P; Hansmann UHE
J Phys Chem B; 2024 May; 128(19):4741-4750. PubMed ID: 38696215
[TBL] [Abstract][Full Text] [Related]
17. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
[TBL] [Abstract][Full Text] [Related]
18. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
[TBL] [Abstract][Full Text] [Related]
19. An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.
Zhao X; Yin Z; Breukink E; Moll GN; Kuipers OP
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179527
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of nisin AB dicarba analogs using ring-closing metathesis: influence of sp(3) versus sp(2) hybridization of the α-carbon atom of residues dehydrobutyrine-2 and dehydroalanine-5 on the lipid II binding affinity.
Slootweg JC; van Herwerden EF; van Doremalen MF; Breukink E; Liskamp RM; Rijkers DT
Org Biomol Chem; 2015 Jun; 13(21):5997-6009. PubMed ID: 25940216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
